Delirium Monograph - Update, Spring 2014
|
|
- Emily Robbins
- 5 years ago
- Views:
Transcription
1 Delirium Monograph - Update, Spring 2014 Since publication of the APM monograph on Delirium in January 2012, three structured reviews have been published adding data relevant to the practice of identification, prevention, and treatment of delirium. Friedman JI, Suleiman L, McGonagall DP, Ego C, Silverstein JH. Pharmacologic Treatments of Non-Substance-Withdrawal Delirium: A Systematic Review of Prospective Trials. American Journal of Psychiatry.2014; 171: This is a report of a systematic literature search and review of data from prospective trials of pharmacological interventions for treatment and prevention of delirium. The authors included randomized and non-randomized double or single blind and open label clinical trials of any pharmacologic agent for the prevention or treatment of delirium. Outcomes included safety and efficacy of interventions for prevention and treatment of delirium, benefits of interventions for reduction of duration and severity of established delirium episodes. This review also sought to evaluate evidence for effectiveness of treatment in reaching specific goals of reduction of reducing intensive care unit and hospital lengths of stay and reduction of mortality. Finally, the authors focused on a limited number of studies of effectiveness of treatment for various delirium subtypes. The search included English language publications from 1980 to late Case reports, retrospective studies or treatments involving substance use disorders were excluded. 45 studies were included in the review. Results were categorized as: 1) antipsychotics for prevention, 2) antipsychotic treatment for on-going delirium, 3) cholinesterase inhibitors, 4) anesthetic techniques perioperative sedation and 5) miscellaneous. Six of seven antipsychotic trials for prevention of delirium in patients undergoing surgical procedures were included. Three studies involved use of haloperidol. Two studies (N=537) demonstrated lower rates of postoperative delirium utilizing intravenous haloperidol while one negative trial (N=430) evaluated oral haloperidol. Use of both oral risperidione (N=227) and olanzapine (N=400) demonstrated reduced levels of postoperative delirium versus control. Four studies of dexmedetomidine sedation in ICU settings showed reduced rates of delirium and adequate sedation. One study involving a single dosages of ketamine and another single study using melatonin showed enhanced efficacy in preventing delirium in general medical patients. Three randomized, double blind, placebo-controlled trials of antipsychotic treatment in patients with ongoing delirium demonstrated that haloperidol, ziprasidone and quetiapine were not associated differentially with higher rates of Delirium Monograph Update, Spring
2 delirium resolution. Effects on episode duration and severity were inconsistent. Quetiapine use was associated with a shorter duration of delirium in one study (N=36) and more rapid resolution in another (N=32). Decreases in ICU or total hospital length of stay could not be demonstrated with use of haloperidol, ziprasidone or quetiapine in treatment of ongoing delirium. Shorter time to extubation for mechanically ventilated patients was demonstrated in several reports (N=202). While prolongation of QTc interval is a potential concern with antipsychotics, this was the least reported adverse effect reported in trials. Data from four delirium trials demonstrated that low-dose intravenous bolus haloperidol, oral haloperidol, oral risperidone, ziprasidone and quetiapine were no more likely than placebo to produce a QTc change greater than 60 ms over baseline or above 500 ms. Continuous intravenous infusion of haloperidol was associated with a significantly longer mean QTc interval than dexmedetomidine. Five studies using cholinesterase inhibitors (N=277) failed to show efficacy in prevention of delirium in surgical patients.. A variety of interventions for enhanced perioperative analgesia demonstrated effectiveness for use of nerve blocks where the surgical site was distal to the block. Three trials of gabapentin involving 380 patients showed modest reductions of postoperative delirium. One trial involving use of opioids to lessen delirium by treating postoperative pain was negative. Three of the 24 antipsychotic trials analyzed treatment effects based on delirium subtypes. Delirium resolution occurred in a greater proportion of hypoactive than hyperactive subtypes with aripiperazole treatment (100 vs. 58.3%). Resolution rates in hypoactive and hyperactive subtypes were similar in one haloperidol trial (77.8 vs. 75%). Lower resolution rates in hypoactive than hyperactive subtypes were reported with use of quetiapine (48% vs. 83%). Teslyar P, Stock VM, Wilk CM, Camsari U, Ehrenreich MJ, Himelhoch S. Prophylaxis with Antipsychotic Medication Reduces the Risk of Post-Operative Delirium in Elderly Patients: a Meta-Analysis. Psychosomatics 2013;54: This report of a meta-analysis of randomized controlled trials of three antipsychotic agents attempts to determine the effect of pretreatment or prophylaxis on the development, severity and length of delirium following common surgical procedures. Four authors conducted independent database searches of English language papers relating to prophylaxis of delirium using antipsychotic medication published between January 1950 and April Search terms included delirium, encephalopathy, ICU psychosis, prevention, antipsychotic and prophylaxis. Inclusion Delirium Monograph Update, Spring
3 criteria included use of antipsychotic treatment of delirium, randomized and placebo controlled, prevention and use of a validated method of delirium diagnosis. All returned the identical five articles (inter-rater reliability of 100%) that included a total of 1491 participants. Analysis of the pooled data suggested a 50% reduction in the relative risk for development of delirium among those receiving an antipsychotic. Other related observations were for a trend lacking statistical significance of decreased severity and length of delirium, decreased length of stay and likelihood that the patient returned home rather than to institutional aftercare. For the primary outcome, prevention of delirium, the numbers needed to treat ranged between 4 and 12. Three antipsychotics, haloperidol, risperidone and olanzapine were utilized. No differences in relative efficacy were detected. There were no adverse effects attributable to antipsychotic use in any of the 739 patients receiving them. Conclusion: Brief, limited use of antipsychotic prophylaxis in the elderly who are at risk for delirium may reduce the incidence of delirium and reduce its associated mortality, disease burden, length of hospital stays and costs. Barr J, Fraser GL, Puntillo K et al. Clinical Practice Guidelines for the Management of Pain, Agitation and Delirium in Adult Patients in the Intensive Care Unit. Journal of Critical Care Medicine. 2013;41(1): The American College of Critical Care Medicine assembled a 20 person multidisciplinary task force with expertise in guideline development charged with updating evidence-based protocols for treatment of pain, agitation and delirium in critically ill patients. Group consensus was reached using the Delphi Method after review of relevant literature using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method through December, The following recommendations were advanced relating to delirium. 1. Delirium is associated with increased mortality, increased ICU and hospital length of stay, and post-icu cognitive impairment in adult ICU patients. 2. Routine monitoring of all ICU patients for delirium using the Confusional Assessment Method (CAM-ICU) is recommended and feasible in everyday practice. 3. In mechanically ventilated adult ICU patients at risk for developing delirium dexmedetomidine infusions may be associated with a lower prevalence of delirium than with benzodiazepine sedation. 4. Evidence does not support a recommendation for the use of haloperidol, second-generation antipsychotics or dexmedetomidine to prevent delirium in the ICU. Delirium Monograph Update, Spring
4 5. There is no evidence that use of haloperidol reduces length of delirium in ICU patients. Second generation antipsychotics may reduce duration of delirium in critically ill patients. 6. Use of antipsychotics in patients with a history of arrhythmia or elevation of QTc interval over baseline is not recommended in the ICU. 7. Suggestion that adult ICU patients with delirium unrelated to alcohol or benzodiazepine withdrawal receive dexmedetomidine rather than other sedating agents to reduce duration of delirium. Commentary: Since the publication of the APM Delirium Guidelines several systematic reviews have added evidence informing practice for Consultation/ Liaison Psychiatrists The 2012 APM Delirium monograph mentioned, but offered no recommendation for, use of pharmacological interventions to reduce frequency of onset of delirium in patients at high risk (elderly, cognitive impaired, prior history of delirium). Additional data and analysis of previously available data suggests that use of haloperidol, olanzapine or risperidone pre-operatively may reduce the incidence, severity of delirium and reduce lengths of stay in patients undergoing common surgical procedures where delirium is a common complication. While there is no FDA approved indication for use of antipsychotics in the prevention or treatment of delirium accumulating evidence supports offering such treatment to reduce associated morbidities. Similar use in critically ill ICU patients, however, is not supported by existing evidence. Use of oral haloperidol, quetiapine and risperidone have not been associated in with safety concerns in studies of treatment or prevention of delirium with the exception of intravenously infused haloperidol associated with increased QTc and arrhythmias. Some light has been shed since the original monograph on use of second-generation antipsychotics used as interventions for delirium. Several such agents, risperidone, quetiapine, olanzaoine, ziprasidone and aripiperazole are equally useful in reducing symptoms of delirium. Efficacy has been demonstrated in a variety of delirium subtypes including hypoactive delirium. The alpha 2 agonist dexmedetomidine was not mentioned in the 2012 APM Delirium Monograph. This agent may be useful in managing sedation in delirious critically ill ICU patients having demonstrated advantages over benzodiazepine sedation. The potential for development of bradycardia or hypotension limits its use to patient with ongoing cardiac and blood pressure monitoring. Delirium Monograph Update, Spring
5 Structured screening for delirium using the Confusional Assessment Method (CAM- ICU) in critically ill ICU patients can improve early identification and indicated intervention for episodes of delirium. Finally, further research is needed in identifying the advantages of various agents in the treatment of established delirium episodes. While data supports use of antipsychotics in prevention of delirium in patients undergoing common surgical procedures, more data is needed relating to actual reduction of morbidities, lengths of stay, post surgical cognitive deficits and costs of care. Thomas M Penders MS, MD Guidelines & Evidenced-Based Medicine Subcommittee Delirium Monograph Update, Spring
Fighting the Fog A Collaborative Approach to Decreasing ICU Delirium
Fighting the Fog A Collaborative Approach to Decreasing ICU Delirium Kimberly Scherr NP Jennifer Barker RN Misericordia Hospital ICU Edmonton, AB CACCN Dynamics Sept 21, 2014 Delirium Delirium is an acute
More informationDELIRIUM IN ICU: Prevention and Management. Milind Baldi
DELIRIUM IN ICU: Prevention and Management Milind Baldi Contents Introduction Risk factors Assessment Prevention Management Introduction Delirium is a syndrome characterized by acute cerebral dysfunction
More informationICU Delirium in Infants & Children: Cause for Concern or False Alarm. Objectives
ICU Delirium in Infants & Children: Cause for Concern or False Alarm Peter (Pete) N. Johnson, Pharm.D., BCPS, BCPPS, FPPAG Associate Professor of Pharmacy Practice University of Oklahoma College of Pharmacy
More informationSarah V. Cogle, PharmD, BCCCP Assistant Clinical Professor Auburn University Harrison School of Pharmacy Auburn, AL ALSHP Annual Clinical Meeting
Sarah V. Cogle, PharmD, BCCCP Assistant Clinical Professor Auburn University Harrison School of Pharmacy Auburn, AL ALSHP Annual Clinical Meeting 2018 I have no actual or potential conflict of interest
More informationManagement of Delirium in the ICU. Yahya Shehabi
Management of Delirium in the ICU Yahya Shehabi Hello! Doctor, your patient is CAM + ve Good morning Dr, Am one of the RC, Just examined Mr XXX he is CAM +ve Positive what? Sir replied RC: I meant he is
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationDrug induced delirium
Drug induced delirium Knut Erik Hovda, MD, PhD, FACMT, FEAPCCT The Norwegian CBRNe Centre of Medicine Department of Acute Medicine Oslo University hospital Content 1. Introduction 2. Risk factors 3. Prevalence
More informationManaging Delirium: The best way to achieve clarity (of mind) Tim Walsh. Professor of Critical Care, Edinburgh University
Managing Delirium: The best way to achieve clarity (of mind) Tim Walsh Professor of Critical Care, Edinburgh University Lecture Plan: a route to clarity What is delirium? Why is delirium important? Step
More informationDelirium in the ICU: Prevention and Treatment. Delirium Defined Officially. Delirium: Really Defined. S. Andrew Josephson, MD
Delirium in the ICU: Prevention and Treatment S. Andrew Josephson, MD Director, Neurohospitalist Service Medical Director, Inpatient Neurology June 2, 2011 Delirium Defined Officially (DSM-IV-TR) criteria
More informationICU Liberation for the Pharmacist. A. Kendall Gross, PharmD, BCPS, BCCCP Critical Care Pharmacist UCSF Medical Center
ICU Liberation for the Pharmacist A. Kendall Gross, PharmD, BCPS, BCCCP Critical Care Pharmacist UCSF Medical Center Disclosure No conflicts of interest to disclose Objectives o Outline the elements of
More informationClinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients
Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit January 2013 Volume 41 Number 1 Society of Critical Care Medicine 本檔僅供內部教學使用檔案內所使用之照片之版權仍屬於原期刊公開使用時,
More informationCanadian Practices for the Treatment of Delirium. Lisa Burry, BScPharm, PharmD
Canadian Practices for the Treatment of Delirium Lisa Burry, BScPharm, PharmD Disclosures & Acknowledgements Conflicts of interest: None Acknowledgements: our patients and the clinical staff that supported
More informationSummary of Delirium Clinical Practice Guideline Recommendations Post Operative
Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;
More informationCritical Care Pharmacological Management of Delirium
Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care
More informationManagement of Delirium in the Elderly Patients: A Review of Evidence
Review Article imedpub Journals http://journals.imedpub.com Journal of Drug Abuse 2471-853X DOI: 10.21767/2471-853X.10006 Abstract Management of Delirium in the Elderly Patients: A Review of Evidence Delirium
More informationCambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information
Organic disorders 1 Delirium Based on Delirium by Laura Gage and David K. Conn in Effective Treatments in Psychiatry, Cambridge University Press, 2008 Introduction Delirium needs treatment for both its
More informationg Prevention, Diagnosis, and Management in Palliative Care
8/3/2012 Improving p g Prevention, Diagnosis, g and Management in Palliative Care MN Rural Palliative Care Networking Group Quarterly Education Session June 27,2012 Sandra W. Gordon-Kolb, MD, MMM, CPE
More informationICU Delirium: Recognition, Management and Long-Term Outcomes
ICU Delirium: Recognition, Management and Long-Term Outcomes Sandy Staveski RN, PhD, CPNP-AC/PC, CNS Assistant Professor, Nurse Scientist Cincinnati Children s Hospital Medical Center Research in Patient
More informationDelirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care
Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define
More informationDelirium. Dr. John Puxty
Delirium Dr. John Puxty Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors, causes and main
More informationOverview of Presentation. Delirium Definition. Assessing & Managing ICU Delirium: What is the Evidence?
Assessing & Managing ICU Delirium: What is the Evidence? Dale Needham, MD, PhD Professor Pulmonary & Critical Care Medicine, and Physical Medicine & Rehabilitation Medical Director, Critical Care Physical
More information5 older patients become delirious every minute
Management of Delirium: Nonpharmacologic and Pharmacologic Approaches Sharon K. Inouye, M.D., M.P.H. Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Milton and Shirley
More informationCritical Care Strategic Clinical Network Provincial ICU Delirium Framework
Pain assessed and documentation using validated tool (CPOT and NRS) Assess and document q4h and prn 100% of patients assessed for pain and documented q4h A: Assess, Prevent & Manage Pain Self Reporting
More informationDelirium and Dementia. Summary
Delirium and Dementia Paul Kettl, M.D., M.H.A. Summary DELIRIUM Acute brain failure Identify cause (meds, infection) Treat sx Poor prognostic sign DEMENTIA Chronic brain failure AD most common cause Often
More informationCritical Care Pharmacological Management of Delirium
Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care
More informationDelirium in Cancer: Psychopharmacologic Management
Delirium in Cancer: Psychopharmacologic Management William Breitbart, MD Professor and Chief, Psychiatry Service Memorial Sloan-Kettering Cancer Center New York, New York Delirium in Patients with Cancer
More informationCollaborative Regional Benchmarking Group (North of England, North Yorkshire & Humber and West Yorkshire)
Best Practice Guidance Sedation These recommendations are bound by the current evidence and best practice at the time of writing and so will be subject to change as further developments are made in this
More informationDelirium. Approach. Symptom Update Masterclass:
Symptom Update Masterclass: Delirium Jason Boland Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine Wolfson Centre for Palliative Care Research Hull York Medical School University
More informationVentilator-Associated Event Prevention: Innovations
Ventilator-Associated Event Prevention: Innovations Michael J. Apostolakos, MD Professor of Medicine Director, Adult Critical Care University of Rochester Mobility/Sedation in the ICU Old teaching: Keep
More informationDelirium in Hospital Care
Delirium in Hospital Care Dr John Puxty 1 Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors,
More informationTrial Results. Intervention Group Imbalances
Trial Results Table S1: Antipsychotic treatment trials for the prevention of delirium (reference numbers refer to references listed at the end of this document). RD=Risk Model for (66), DSM-IV=Diagnostic
More informationDexmedetomidine: the various roles and utilization strategies. Julie Belfer, PharmD September 2014
Dexmedetomidine: the various roles and utilization strategies Julie Belfer, PharmD September 2014 Disclosure No disclosures concerning possible financial or personal relationships with commercial entities
More informationA17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013
A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013 Clay Angel, MD, Hospital Medicine; Chief of Continuum/SNF Kristen
More informationPharmacological Treatment of Aggression in the Elderly
Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question
More informationSedation and Delirium Questions
Sedation and Delirium Questions TLC Curriculum William J. Ehlenbach, MD MSc Assistant Professor of Medicine Pulmonary & Critical Care Medicine Question 1 Deep sedation in ventilated critically patients
More informationDelirium in the Elderly
Delirium in the Elderly Jeffrey M. Burock, MD Division Director/ Psychiatry / Miriam Hospital Clinical Assistant Professor Warren Alpert School Of Medicine Learning Objectives Identify the symptoms of
More informationICU Updates: Delirium in Hospitalized Patients
Outline James A. Frank, MD Associate Professor Pulmonary and Critical Care UCSF Dept. of Medicine Director, MICU San Francisco VAMC ICU Updates: in Hospitalized Patients Recognizing and preventing delirium
More informationUSING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?
USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE? Mugdha Thakur, MD Associate Professor of Psychiatry and Behavioral Sciences Duke University
More informationDelirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen
Delirium Dr. Lesley Wiesenfeld Deputy Psychiatrist in Chief, Mount Sinai Hospital Dr. Carole Cohen Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre Case Study Mrs B
More informationChapter 161 Antipsychotics
Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in
More informationEvidence-Based Treatment of Delirium in Patients With Cancer William Breitbart and Yesne Alici
Published Ahead of Print on March 12, 2012 as 10.1200/JCO.2011.39.8784 The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/jco.2011.39.8784 JOURNAL OF CLINICAL ONCOLOGY R E V I E W A R T I
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme Recommendation for Guidance Executive (post-consultation) Clinical guideline CG103: Delirium: diagnosis,
More informationJennifer Mando-Vandrick, PharmD, BCPS Clinical Pharmacist, Emergency Department Director, PGY2 Critical Care Pharmacy Residency Duke University
Jennifer Mando-Vandrick, PharmD, BCPS Clinical Pharmacist, Emergency Department Director, PGY2 Critical Care Pharmacy Residency Duke University Hospital Objectives Review pertinent pharmacotherapy common
More informationConflict of Interest. Patient Case. Objectives. The Balancing Act. Why We Need Sedation
Agitation in the ICU Have we swung the pendulum too far from benzodiazepines? Conflict of Interest The author of this presentation has no conflicts of interest to disclose Nina Vadiei, PharmD PGY1 Pharmacy
More informationImportance of Training and Quality Control of Post-Operative Delirium Assessment:
Importance of Training and Quality Control of Post-Operative Delirium Assessment: Hochang Benjamin Lee, M.D. Associate Professor of Psychiatry Yale University School of Medicine Director, Psychological
More information+ Change in baseline mental status, inattention, and either disorganized thinking or altered level of consciousness. Delirium. Disclosure.
47 th Annual Meeting August 2-4, 2013 Orlando, FL Identification, Prevention and Treatment of Delirium: The Role of the Health System Pharmacist Jennifer Cortes, PharmD, BCPS Medical ICU Clinical Pharmacy
More informationICU Updates: Delirium in Hospitalized Patients
ICU Updates: Delirium in Hospitalized Patients James A. Frank, MD Associate Professor Pulmonary and Critical Care UCSF Dept. of Medicine Director, MICU San Francisco VAMC Recognizing and preventing delirium
More informationDIAH MUSTIKA HW SpS,KIC Intensive Care Unit of Emergency Department Naval Hospital dr RAMELAN, Surabaya
DIAH MUSTIKA HW SpS,KIC Intensive Care Unit of Emergency Department Naval Hospital dr RAMELAN, Surabaya Encephalopathy is a common complication of systemic illness or direct brain injury. Acute confusional
More informationDelirium in Critical Care. Recognition, Management, Research tasters. Dr Valerie Page Watford General Hospital
Delirium in Critical Care. Recognition, Management, Research tasters Dr Valerie Page Watford General Hospital What does it look like? Diagnosing delirium CAM-ICU CAM-ICU Feature 1: Acute onset of mental
More informationDelirium is a frequent complication in the ICU setting.
Clinical Investigations Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial* Genís Carrasco, PhD, MD; Nacho
More informationDELIRIUM IN THE PICU ALLISON M. CHUNG, PHARM.D., BCPPS, BCPS, FCCP
DELIRIUM IN THE PICU ALLISON M. CHUNG, PHARM.D., BCPPS, BCPS, FCCP Associate Professor Auburn University Harrison School of Pharmacy Adjunct Professor University of South Alabama, Children and Women s
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Page VJ, Casarin A, Ely EW, et al. Evaluation
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2017 Liza Genao, MD Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity Very much under-recognized
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2015 Mamata Yanamadala M.B.B.S, MS Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity
More informationManagement of delirium in mechanically ventilated patients. Advances in Critical Care Medicine King Hussein Cancer Center
Management of delirium in mechanically ventilated patients Advances in Critical Care Medicine King Hussein Cancer Center Introduction Outline: Prevalence of delirium in ICU Why it is important to screen
More informationRole of Quetiapine in an Adult Critical Care Practice
American Journal of Pharmacology and Pharmacotherapeutics Short Communication Role of Quetiapine in an Adult Critical Care Practice Vikram Anumakonda* Dudley Group of Hospitals NHS Foundation Trust Birmingham,
More informationImproving Delirium Management: Mapping Out One Unit s Journey. Geriatrics Institute June 27, 2013
Improving Delirium Management: Mapping Out One Unit s Journey Geriatrics Institute June 27, 2013 Rebecca Ramsden, NP Mary Ann Hamelin, CNS Susanne Loay, RN Objectives Background RNAO Best Practice Guideline
More informationOptimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)
Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS) Georgios Dadoudis Anesthesiologist ICU DIRECTOR INTERBALKAN MEDICAL CENTER Optimal performance requires:
More informationPsychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD
Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences
More informationDelirium, The Geriatrics Ward Challenge
American Journal of Pharmacology and Pharmacotherapeutics Research Article Delirium, The Geriatrics Ward Challenge Pardo Pastor Ricardo Fernandes 1, Rafaela Veríssimo 2 and António Agripino Oliveira 3*
More information5 older patients become. What is delirium? (Acute confusional state) Where We ve Been and
Update on Delirium: Where We ve Been and Where We re Going Sharon K. Inouye, M.D., M.P.H. M PH Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Milton and Shirley F. Levy
More informationDelirium in the intensive care unit: a narrative review of published assessment tools and the relationship between ICU delirium and clinical outcomes
The Intensive Care Society 2008 Delirium in the intensive care unit: a narrative review of published assessment tools and the relationship between ICU delirium and clinical outcomes C Waters Delirium is
More informationAdaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition
Iran J Psychiatry 2018; 13: 1: 65-79 Review Adaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition Mohammad Arbabi 1, Fatemeh Shahhatami 2, Mojtaba
More informationPOST-INTUBATION ANALGESIA AND SEDATION. August 2012 J Pelletier
POST-INTUBATION ANALGESIA AND SEDATION August 2012 J Pelletier Intubated patients experience pain and anxiety Mechanical ventilation, endotracheal tube Blood draws, positioning, suctioning Surgical procedures,
More informationSedation and delirium- drugs and clinical management
Sedation and delirium- drugs and clinical management Shannon S. Carson, MD Associate Professor and Chief Division of Pulmonary and Critical Care Medicine University of North Carolina Probability of transitioning
More informationDEMENTIA AND MEDICATION
DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationNuplazid. (pimavanserin) New Product Slideshow
Nuplazid (pimavanserin) New Product Slideshow Introduction Brand name: Nuplazid Generic name: Pimavanserin Pharmacological class: Atypical antipsychotic Strength and Formulation: 17mg; tablets Manufacturer:
More informationford residence southampton, ny
P ford residence southampton, ny 5-2-1 sedation haldol ativan Sedation/Pain Control/Anesthesia 2: Management of Combative, Agitated, Delirious Patients. The manifestations of an acute.. Combination of
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency
More informationDelirium. Quick reference guide. Issue date: July Diagnosis, prevention and management
Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide
More information( delirium ) 15%- ( extrapyramidal syndrome ) risperidone olanzapine ( extrapyramidal side effect ) olanzapine ( Delirium Rating Scale, DRS )
2005 6 48-52 Olanzapine 30% ( delirium 5%- Haloperidol ( extrapyramidal syndrome risperidone ( extrapyramidal side effect ( Delirium Rating Scale, DRS ( Delirium ( Olanzapine ( Delirium Rating Scale, DRS
More informationAnalgesia, Sedation and Delirium The Latest Evidence in Assessment & Treatment
Analgesia, Sedation and Delirium The Latest Evidence in Assessment & Treatment Julie Miller, RN, BSN, CCRN How many of you routinely assess for delirium in your patients? 2013 SCCM Guidelines Pain Recommend
More informationCare of the Acutely Agitated Patient. Objectives. Agitation Defined
Care of the Acutely Agitated Patient James C. Hardy, MD Assistant Professor of Emergency Medicine Department of Emergency Medicine, UCSF Dealing with combative patients is one of the most difficult challenges
More informationAppendix N: Research recommendations
Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist
More informationImplementation of a Delirium Screening Tool in a Pediatric Intensive Care Unit
Implementation of a Delirium Screening Tool in a Pediatric Intensive Care Unit BY: ABBY WACHHOLTZ, BSN, RN, PEDIATRIC ACUTE CARE DNP STUDENT Disclosures I have no disclosures. 1 Objectives 1. Recognize
More informationKendiss Olafson MD FRCPC MPH Section of Critical Care University of Manitoba
Kendiss Olafson MD FRCPC MPH Section of Critical Care University of Manitoba Outline Sedation in ICU Purpose/Goals Common Drugs Sedation delivery strategies Mobility in the ICU Weakness with critical illness
More informationWAKE UP AND TREAT DELIRIUM : PITFALLS OF THE PAD GUIDELINES
WAKE UP AND TREAT DELIRIUM : PITFALLS OF THE PAD GUIDELINES Tudy Hodgman, Pharm D, FCCM, BCPS The goal of this discussion will be to review the literature published since the PAD guidelines were released
More informationCharles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018
Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018 Delirium common Prolongs hospitalization Worsens dementia ( if you survive) Increased risk of institutionalization
More informationEfficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L
Efficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L CRD summary This review evaluated the efficacy of post-operative epidural analgesia. The authors
More informationDelirium: Prevention with Melatonin
Delirium: Prevention with Melatonin Lisa Burry, PharmD Department of Pharmacy, Mount Sinai Hospital Leslie Dan Faculty of Pharmacy, University of Toronto Disclosures Centre for Collaborative Drug Research,
More informationLearning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016
Terminal Restlessness Dr. Christopher Churchill St. Cloud VA Health Care System EC&R Service Line Director & Medical Director Hospice & Palliative Care March 31, 2016 Learning Objectives Different Terminology
More informationIncreasing post-operative delirium in cardiac surgery patients. Karen Kindness Hussein El-Shafei Lisa Lawman
Increasing post-operative delirium in cardiac surgery patients. Karen Kindness Hussein El-Shafei Lisa Lawman Introduction why is it a problem? CTUs can expect to encounter pts with postoperative delirium/psychosis
More informationSIGN157. Risk reduction and management of delirium. A national clinical guideline
SIGN157 Risk reduction and management of delirium A national clinical guideline March 2019 Key to evidence statements and recommendations Levels of evidence 1 ++ High-quality meta-analyses, systematic
More informationComfort Management in the Adult with Congenital Heart Disease What the ICU Bedside Nurse Needs to Know
Comfort Management in the Adult with Congenital Heart Disease What the ICU Bedside Nurse Needs to Know Sandy Staveski RN, MS, CPNP-AC/PC, CNS, CCRN Pediatric Intensive Care Nurse Practitioner Lucile Packard
More informationPHYSICIAN'S ORDERS Mark in for desired orders. If is blank, order is inactive. VENTILATOR SEDATION / ANALGESIC / DELIRIUM ORDER
Nursing Daily awakenings PHYSICIAN'S ORDERS Mark in for desired orders. If is blank, order is inactive. VENTILATOR SEDATION / ANALGESIC / DELIRIUM ORDER Do not perform daily awakenings: Rationale: Daily
More informationDelirium in the Neurologically Injured
Fifth Annual Baptist Health South Florida Miami Neuro Nursing Symposium 2017 Delirium in the Neurologically Injured Financial Disclosure Financial relationships none Product endorsements none Financial
More informationBehavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.
Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS
More informationDELIRIUM. Approach and Management
DELIRIUM Approach and Management By Dr. K.S. Jacob, Professor of Psychiatry and Dr. Anju Kuruvilla, Professor of Psychiatry, Christian Medical College, Vellore. Based on a chapter in the book Psychiatric
More informationICU LIBERATION: IMPLEMENTING THE ABCDEF BUNDLE AND IMPROVING THE LIVES OF ICU PATIENTS
ICU LIBERATION: IMPLEMENTING THE ABCDEF BUNDLE AND IMPROVING THE LIVES OF ICU PATIENTS J. MATTHEW ALDRICH, MD ASSOCIATE CLINICAL PROFESSOR OF ANESTHESIA AND PERIOPERATIVE CARE UNIVERSITY OF CALIFORNIA
More informationDelirium in Older Persons
Objectives Delirium in Older Persons ELITE 2018 Liza Isabel Genao, MD Division of Geriatrics Describe rate, cost, complications of delirium Effectively diagnose the syndrome Describe multicomponent model
More informationDecember page 1 / 10
December 2018 page 1 / 10 Neurology Advising on this article: Jack J. Chen December 3, 2018 Switching antiepileptic suppliers associated with increased seizure risk? Switching the manufacturer of antiepileptic
More informationManagement of Agitation in Dementia. Kimberly Triplett Ferguson, MS4
Management of Agitation in Dementia Kimberly Triplett Ferguson, MS4 Objectives 1. Review recommended evaluation of agitated patients with dementia. 2. Discuss evidence concerning nonpharmacologic management.
More informationConducting Delirium Research
Optimizing Clinical Trials When Conducting Research Research funding: Disclosure NHLBI, NIA, AstraZeneca John W. Devlin, PharmD, FCCP, FCCM, Professor of Pharmacy, Northeastern University Scientific Staff,
More informationQuiz 35. This quiz is being published on behalf of the Education Committee of the SNACC. Start. Postoperative delirium - Px and Rx
Quiz 35 Postoperative delirium - Px and Rx SUNEETA GOLLAPUDY, M.D ASSOCIATE PROFESSOR, DIRECTOR OF NEUROANESTHESIA, MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WI QUIZ TEAM: SHOBANA RAJAN, M.D; SUNEETA GOLLAPUDY,
More informationAbbreviated Class Review: Long-Acting Injectable Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationImproving the Management of Pain, Agitation, and Delirium (PAD) in the Intensive Care Unit: Translating Evidence Into Practice
Improving the Management of Pain, Agitation, and Delirium (PAD) in the Intensive Care Unit: Translating Evidence Into Practice Christine M. Groth, Pharm.D., BCCCP NYS Partnership for Patients September
More information